Real World Assessment of Once-a-Month Dosing of Lebrikizumab in Commercial Claims. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 Apr. 30];10(2):s747. Available from: https://skin.dermsquared.com/skin/article/view/4118